| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/07/2009 | EP2010512A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 01/07/2009 | EP2010511A1 Chromen-2-one derivatives |
| 01/07/2009 | EP2010510A1 Use of a lactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity |
| 01/07/2009 | EP2010509A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers |
| 01/07/2009 | EP2010508A1 Thiazol-guanidine derivatives useful as a (beta)- related pathologies |
| 01/07/2009 | EP2010506A1 Diazepan derivatives modulators of chemokine receptors |
| 01/07/2009 | EP2010505A2 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 01/07/2009 | EP2010504A1 Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/07/2009 | EP2010503A1 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists |
| 01/07/2009 | EP2010502A1 Pyrimidine derivatives for the treatment of amyloid-related diseases |
| 01/07/2009 | EP2010501A2 Imidazole-based compounds, compositions comprising them and methods of their use |
| 01/07/2009 | EP2010499A1 Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns |
| 01/07/2009 | EP2010498A1 Synthesis of acylaminoalkenylene amides useful as substance p antagonists |
| 01/07/2009 | EP2010497A1 Compositions and methods for modulating gated ion channels |
| 01/07/2009 | EP2010490A2 Crystalline forms of a dimethylphenyl compound |
| 01/07/2009 | EP2010489A2 Dialkylphenyl compounds having 2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 01/07/2009 | EP2010488A2 Renin inhibitors |
| 01/07/2009 | EP2010487A1 5-amido-2-carboxamide indoles |
| 01/07/2009 | EP2010486A2 Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods |
| 01/07/2009 | EP2010485A1 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists |
| 01/07/2009 | EP2010483A2 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof |
| 01/07/2009 | EP2010479A1 11 beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/07/2009 | EP2010476A2 C-nitroso-derived nitroxyl donors |
| 01/07/2009 | EP2010289A2 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol |
| 01/07/2009 | EP2010224A2 Method and composition for treating and preventing tumor metastasis in vivo |
| 01/07/2009 | EP2010220A2 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them |
| 01/07/2009 | EP2010218A2 Compositions comprising pyruvate alkyl esters and uses thereof |
| 01/07/2009 | EP2010198A2 Non-starchy rice bran polysaccharides |
| 01/07/2009 | EP2010194A2 Hydroxylated polymethoxyflavone compositions |
| 01/07/2009 | EP2010192A2 Apparatus and methods for pain relief using ultrasound energized polymers |
| 01/07/2009 | EP2010191A2 Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines |
| 01/07/2009 | EP2010190A2 Pharmaceutical solution formulations for pressurised metered dose inhalers |
| 01/07/2009 | EP2010189A2 Osmotic drug delivery system comprising release enhancing agent |
| 01/07/2009 | EP2010188A2 Chromium complexes |
| 01/07/2009 | EP2010187A2 Compounds for diseases and disorders |
| 01/07/2009 | EP2010186A1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 01/07/2009 | EP2010185A1 Dihydrothienopyrimidine for treating inflammatory disorders |
| 01/07/2009 | EP2010184A2 Implants for the treatment of dopamine associated states |
| 01/07/2009 | EP2010182A2 Use of c-src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia |
| 01/07/2009 | EP2010181A1 Methods of treating cell proliferative disorders by using pyrimidinediamine compounds |
| 01/07/2009 | EP2010180A2 Il-8 receptor antagonists |
| 01/07/2009 | EP2010179A2 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
| 01/07/2009 | EP2010178A2 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
| 01/07/2009 | EP2010176A2 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 01/07/2009 | EP2010175A1 Piperidine derivatives useful for treating osteoarthritis and osteoartrosis |
| 01/07/2009 | EP2010173A1 Compounds for treating pulmonary hypertension |
| 01/07/2009 | EP2010172A2 Indoles and benzoimidazoles as modulators of the histamine h4 receptor |
| 01/07/2009 | EP2010171A2 Inhibitors of pai-1 for treatment of muscular conditions |
| 01/07/2009 | EP2010170A2 Use of biarylcarboxamides in the treatment of hedgehog pathway-related disorders |
| 01/07/2009 | EP2010169A2 The genetic risk assessment in heart failure: impact of the genetic variation of g-protein beta 3 subunit polymorphism |
| 01/07/2009 | EP2010167A2 Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis |
| 01/07/2009 | EP2010165A2 Abnormal cannabidiols as agents for lowering intraocular pressure |
| 01/07/2009 | EP2010163A2 Co-crystals of calixarenes and biologically active molecules |
| 01/07/2009 | EP2010156A2 Stabilized compositions containing alkaline labile drugs |
| 01/07/2009 | EP2010154A2 Mask-tasting solid preparation of pioglitazone |
| 01/07/2009 | EP2010151A2 Treatment of triple receptor negative breast cancer |
| 01/07/2009 | EP2010148A2 Composition including at least one aqueous phase and at least one fatty phase including ivermectin |
| 01/07/2009 | EP2010141A2 High-deposition compositions and uses thereof |
| 01/07/2009 | EP2010136A2 Methods for modulating formation and progression of cellulite |
| 01/07/2009 | EP2010133A2 Foamable suspension gel |
| 01/07/2009 | EP2010117A2 Compositions and methods for inhibiting adhesions |
| 01/07/2009 | EP2010096A2 Nasolacrimal drainage system implants for drug therapy |
| 01/07/2009 | EP2010012A1 Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity |
| 01/07/2009 | EP2010005A1 Treatment of poultry for increasing the feed conversion rate or for reducing the incidence of ascites |
| 01/07/2009 | EP2009992A2 Il-8 receptor antagonists |
| 01/07/2009 | EP1963506A4 Compositions and methods for increasing production of recombinant gamma-carboxylated proteins |
| 01/07/2009 | EP1928821B1 Carboxamide derivatives as muscarinic receptor antagonists |
| 01/07/2009 | EP1896031B1 Thiazolopyrimidines for use in therapy |
| 01/07/2009 | EP1890681B1 Dry granulated composition comprising emtricitabine and tenofovir DF |
| 01/07/2009 | EP1858900B1 Fused thiazole derivatives having affinity for the histamine h3 receptor |
| 01/07/2009 | EP1858867B1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
| 01/07/2009 | EP1851234B1 Substituted propane phosphinic acid esters |
| 01/07/2009 | EP1824472B1 Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome |
| 01/07/2009 | EP1807072B1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/07/2009 | EP1797042B1 Indozolone derivatives as 11b-hsd1 inhibitors |
| 01/07/2009 | EP1791872B1 Biotinylated hexadecasaccharides, pharmaceutical compositions and use thereof |
| 01/07/2009 | EP1771443B1 Quinoline thiazolinones with cdk-1 antiproliferative activity |
| 01/07/2009 | EP1771415B1 2- (1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
| 01/07/2009 | EP1759702B1 Method of preparing a latanoprost ophthalmic solution and solution thus produced |
| 01/07/2009 | EP1751155B1 Substituted azachinazolines having an antiviral action |
| 01/07/2009 | EP1735304B1 Quinolinone-carboxamide compounds as 5-ht4 receptor agonists |
| 01/07/2009 | EP1727799B1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products |
| 01/07/2009 | EP1718568A4 Process for preparing water soluble diterpenes and their applications |
| 01/07/2009 | EP1711230B1 Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism |
| 01/07/2009 | EP1699529B1 Antimicrobial compositions containing an aromatic carboxylic acid and a hydric solvent |
| 01/07/2009 | EP1684735A4 Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias |
| 01/07/2009 | EP1680405B1 Bengamide derivatives and use thereof for the treatment of cancer |
| 01/07/2009 | EP1678163B1 Novel imidazole derivatives and their use as pharmaceutical agents |
| 01/07/2009 | EP1667966A4 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 01/07/2009 | EP1663257B1 Use of laxatives for treating irritable bowel syndrome |
| 01/07/2009 | EP1635843B1 Therapy comprising dienogest for hormone replacement and depression |
| 01/07/2009 | EP1594885B1 Medicament for inhibiting tumour growth |
| 01/07/2009 | EP1592416B1 Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis |
| 01/07/2009 | EP1575597B1 Use of rimexolone in the treatment of dry eye |
| 01/07/2009 | EP1569916B1 Substituted aralkyl derivatives |
| 01/07/2009 | EP1562589B1 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/07/2009 | EP1542691B1 Composition for the treatment of nasopharyngeal carcinoma and use thereof |
| 01/07/2009 | EP1534302A4 Arginine silicate inositol complex and use thereof |
| 01/07/2009 | EP1503737B1 Nanoparticulate nystatin formulations |
| 01/07/2009 | EP1499291B1 Methods and dosage forms for controlled delivery of oxycodone |